Sep 2026
Diabetic serum preconditioning augments human umbilical cord mesenchymal stem cell secretome therapeutic efficacy in reversing insulin resistance in 3T3-L1 adipocytes.
BACKGROUND Insulin resistance, metabolic dysfunction, inflammation, and vascular impairment characterize Type 2 Diabetes Mellitus (T2DM). Mesenchymal stem cells (MSCs) have shown promise in preclinical studies. However, their variable efficacy in human settings warrants strategies to enhance their therapeutic potency....
N. Mante, V. Undale, Avinash Sanap et al.
· Tissue & Cell · 0 citations